Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Sep 07, 2026
MasTec (MTZ) Stock Pullback: -11% Over 30 Days and -37% This Quarter

MasTec (MTZ) Stock Pullback: -11% Over 30 Days and -37% This Quarter

Key Takeaways

  • MasTec (MTZ) shares declined about 11% over the last 30 days, ending near $237 from roughly $267 a month earlier.
  • The slide followed a second-quarter 2026 earnings report that beat on revenue but disappointed investors on forward guidance.
  • A record backlog of $21.4 billion and strong clean energy, power delivery, and pipeline results were overshadowed by a softer communications outlook.
  • Over the trailing quarter, the stock has fallen roughly 37% from its early-June level near $375, reflecting a broader reset in expectations.
  • Wall Street has largely maintained Buy and Outperform ratings despite the pullback.

MasTec's Business and Market Position

MasTec, Inc. is a leading North American infrastructure engineering and construction company headquartered in Coral Gables, Florida. The company engineers, builds, installs, maintains, and upgrades critical infrastructure across four reportable segments: Communications (wireless and wireline/fiber), Clean Energy and Infrastructure, Power Delivery, and Pipeline Infrastructure.

MasTec serves utilities, energy producers, telecommunications providers, and hyperscale data center operators, giving it diversified exposure to secular trends such as grid modernization, renewable energy expansion, and AI-driven data center buildouts. Investors follow the stock closely because its record backlog and book-to-bill ratio provide visibility into multi-year infrastructure spending cycles, while its project execution and margin consistency are key measures of earnings quality. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, MasTec shares have fallen approximately 11%. The stock closed at $266.75 on August 5, 2026, and ended at $237.19 on September 4, 2026, as the market continued to digest the company's second-quarter results and revised outlook.

The near-term decline is part of a larger downdraft. Over the trailing three months, MTZ has dropped roughly 37%, sliding from about $375 in early June to its current level near $237. The stock now trades well below its 52-week high of around $441, reached in May 2026, as optimism about its infrastructure growth story has cooled and expectations have been repriced.

Drivers Behind the 30-Day Move

The dominant catalyst was MasTec's second-quarter 2026 earnings report, released after the close on July 30, 2026, and the subsequent investor reaction on July 31, when shares plunged roughly 18.5% in a single session. The company delivered strong headline results: revenue rose 23.4% year over year to a quarterly record of $4.37 billion, adjusted EBITDA increased about 40% to $384.2 million, and adjusted diluted earnings per share climbed 49% to $2.22. The 18-month backlog reached a record $21.4 billion, up 30% year over year.

Yet the market focused on two items. First, adjusted EPS of $2.22 narrowly missed a consensus estimate of $2.23. Second, and more importantly, investors interpreted the company's updated full-year guidance as a reduction relative to prior expectations, particularly in the Communications segment. Management cut its full-year communications revenue outlook to about $3.25 billion, citing lower wireless revenue in the second half and wireline project deferrals tied to delayed spectrum deployments and the roll-off of certain rural broadband programs.

That guidance reset overshadowed otherwise strong results in Clean Energy and Infrastructure (revenue up 43%), Power Delivery (up nearly 20%), and Pipeline Infrastructure (up 19%). MasTec also raised its full-year 2026 outlook to $18.2 billion in revenue and $9.30 in adjusted EPS, though the updated figures remained below some analysts' prior projections. From what I see, the earnings beat on the top line was solid, but the forward view created the real pressure.

Factors Behind the Broader Quarterly Decline

The broader three-month decline reflects a shift from momentum-driven optimism to a more cautious assessment of execution and timing. Earlier in 2026, the stock rallied toward record highs as investors priced in strong demand from data centers, grid modernization, and renewable energy. The acquisition of The Superior Group, a premier electrical contractor with roughly 3,000 employees and a leading position in data center infrastructure, reinforced that narrative.

However, the second-quarter report highlighted that a meaningful portion of newly booked work is weighted toward 2027 and beyond, while communications-related timing issues created near-term uncertainty. Concerns about backlog conversion, margin durability, and the pace of integration following the Superior acquisition combined to compress the stock's valuation premium. The appointment of Alexander Spiro to the board in July 2026 was noted as a governance addition but did not offset the negative sentiment. One thing that stands out is how quickly sentiment shifted once the communications outlook was adjusted.

What to Watch in the Coming Quarters

Looking ahead, several factors are likely to shape MasTec's stock. The company's next quarterly report, estimated for late October 2026, will be a key test of whether its raised full-year guidance remains intact and whether communications revenue stabilizes. Investors will monitor backlog conversion, the pace of new spectrum-related wireless work, and the integration of The Superior Group, which management expects to contribute roughly $800 million in revenue and about $100 million in EBITDA for 2026.

Macroeconomic conditions, including interest rates, utility capital spending, and data center demand, will also influence sentiment. Execution on margin expansion and the timing of cash flow generation, which management expects to be weighted to the fourth quarter, remain important. While analysts have generally kept constructive ratings, the market will be watching for evidence that the company's record backlog translates into consistent earnings growth rather than further guidance revisions. I’m watching this closely as the next earnings release approaches.

Using AI Tools for Stock Analysis

In my own research process, I often turn to Tickeron’s AI Trading Bots to test different strategies on names like this one. The platform lets users compare performance across various timeframes and approaches, which helps put price action into a broader, data-driven context without replacing personal judgment. It has been a useful supplement when reviewing how similar infrastructure names have behaved after earnings resets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MTZ

MTZ's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MTZ turned positive on September 21, 2026. Looking at past instances where MTZ's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MTZ's RSI Indicator exited the oversold zone, 14 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 49 cases where MTZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTZ advanced for three days, in 276 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

MTZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MTZ as a result. In 56 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The 50-day moving average for MTZ moved below the 200-day moving average on September 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for MTZ entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. MTZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.715) is normal, around the industry mean (16.441). P/E Ratio (32.498) is within average values for comparable stocks, (203.442). Projected Growth (PEG Ratio) (0.616) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.007) among similar stocks. P/S Ratio (1.103) is also within normal values, averaging (2.926).

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are MasTec (NYSE:MTZ).

Industry description

Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.

Market Cap

The average market capitalization across the Engineering & Construction Industry is 7.67B. The market cap for tickers in the group ranges from 69 to 2.15T. WKAPF holds the highest valuation in this group at 2.15T. The lowest valued company is WLGSF at 69.

High and low price notable news

The average weekly price growth across all stocks in the Engineering & Construction Industry was 1%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -13%. MSGY experienced the highest price growth at 56%, while FBGL experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Engineering & Construction Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was -53% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 55
Price Growth Rating: 60
SMR Rating: 71
Profit Risk Rating: 75
Seasonality Score: 44 (-100 ... +100)
View a ticker or compare two or three
MTZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a infrastructure construction company

Industry EngineeringConstruction

Industry
Engineering And Construction
Address
800 S. Douglas Road
Phone
+1 305 599-1800
Employees
36000
Web
https://www.mastec.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.